The Fight for Botanicals

At a recent Toledo City Council meeting, community members gathered to express their perspectives on the council’s proposal to ban kratom. The discussion highlighted the passionate engagement of local residents, with individuals speaking both for and against the measure. Many supporters of kratom emphasized its positive role for those seeking alternatives for wellness and relief. Their voices illustrated the significance of thoughtful dialogue and community feedback in public policy decisions.

As the city weighs its options, the exchange of ideas demonstrated the values of open debate and respect for diverse viewpoints. Toledo’s consideration of the proposal is part of a broader conversation about personal choice, health, and regulation. For more details on the story, visit The Blade’s coverage of the meeting.

Florida has moved decisively to protect public health, issuing an emergency rule that classifies isolated and concentrated 7-hydroxymitragynine (7-OH) as a Schedule I controlled substance. The action empowers law enforcement to immediately remove concentrated 7-OH products—often found in shots, capsules, powders, and gummies—from retail shelves statewide. Officials cited rising ER visits and poison control calls, particularly among people under 25, as key drivers for the urgent response. Health leaders praised the move as a targeted step to curb access to potent, concentrated derivatives while signaling a broader push for responsible regulation of unregulated wellness products. Enforcement begins immediately, with the goal of keeping communities safe and informed. Read the original report for full details at MSN.

A fresh wave of attention is shining on kratom, a botanical supplement traditionally used for wellness, as Michigan officials move to distinguish between its natural leaf form and a potent derivative, 7-hydroxymitragynine (7-OH). Recent actions from regulatory figures, such as Health and Human Services Secretary Robert F. Kennedy Jr., clarify that while the FDA seeks stricter oversight on 7-OH, the whole kratom leaf remains legally available for adults.

The state’s proposed laws would introduce standards to ensure kratom products are clearly labeled, free from adulterants, and off-limits to those under 18. Advocates praise the approach as protecting both consumer rights and public safety. For a full report on these developments and what they mean for Michigan residents, see the original coverage by the Detroit Free Press.

The American Kratom Association (AKA) has commended Secretary Kennedy and FDA Commissioner Makary for their recent move to specifically regulate synthetic 7-OH, distinguishing it from the widely used natural kratom plant. In a public statement, the AKA described this as a balanced decision that prioritizes consumer safety while preserving lawful access to natural kratom products.

The association highlighted that synthetic 7-OH is a laboratory-made derivative with far greater risk than kratom in its natural form, which is supported by a longstanding record of responsible use. The AKA praised the federal officials for championing a science-driven approach and underscored the significance for the broader kratom community.

By targeting only synthetic compounds, the new scheduling preserves public access to traditional kratom, which the AKA says benefits countless Americans. For full details, see the official release on Reuters.

Mississippi has introduced new regulations on kratom, a plant-based supplement commonly sold in convenience stores and vape shops. Starting July 1, residents must be at least 21 years old to purchase kratom products—a change driven by health officials’ concerns about safety and a rise in kratom-related incidents in drug courts. In addition, kratom will now be subject to a 25% excise tax, higher than the tax on tobacco.

The new laws also require clear ingredient labeling and registration of products with the state’s Department of Revenue. Synthetic kratom and products with high levels of certain psychoactive compounds are banned, but the legislation stopped short of making kratom a controlled substance requiring a prescription. Supporters of regulation say these steps aim to protect consumers while maintaining access to those who use kratom for relaxation or pain relief.

For further details, read more in the original article.

Kratom, an herbal supplement derived from a Southeast Asian tree, is at the center of a growing debate as cities and states across the U.S. move to ban its sale. Recently, Belchertown, Massachusetts, joined a wave of communities restricting kratom, citing concerns over its unregulated status and potential risks to minors. The ban, finalized in early 2024, followed similar actions in Lowell, Dracut, and Chelmsford, with several states enacting statewide prohibitions.

Despite these crackdowns, advocates highlight kratom’s positives. The American Kratom Association describes it as providing an “energy boost like a cup of coffee” and, at higher doses, helping with anxiety. For some, like Lori Romney—who suffers from severe facial pain—kratom has been transformative, allowing her to stop daily opioid prescriptions and find relief where other treatments failed.

For more details, see the original article at WWLP.com

The American Kratom Association (AKA) has publicly praised the U.S. Food and Drug Administration (FDA) for its recent crackdown on vendors selling products containing dangerous, chemically manipulated compounds such as 7-hydroxymitragynine (7-OH), pseudoindoxyl, and “M”. These substances, often marketed as kratom, are synthetic or highly concentrated versions that appear only in trace amounts in natural kratom and pose significant risks to consumers.

The FDA’s enforcement action included issuing Warning Letters to companies making illegal therapeutic claims and selling unapproved formulations. The agency made clear that such products—often found in tablets, drink mixes, and shots—are considered unapproved drugs and adulterated foods under federal law.

Mac Haddow, senior fellow at the AKA, emphasized that these products mislead consumers and threaten public safety, calling for continued aggressive enforcement. The AKA continues to advocate for stricter state-level regulations to protect consumers and maintain access to safe, natural kratom.

Read the full release at Reuters.

Missourians living with chronic pain are increasingly turning to kratom and its active ingredient, 7-OH, as an alternative to traditional painkillers. Brandi Lane, who endured two decades of persistent pain, credits kratom with restoring her quality of life after years of ineffective treatments and frequent emergency room visits.

Despite its benefits, kratom remains unregulated in Missouri, with no statewide requirements for safety testing, labeling, or age restrictions. Lane warns that this regulatory gap leaves consumers vulnerable and risks a potential ban if a safety incident occurs.

A recent bipartisan effort to introduce basic safety measures—such as ingredient testing and dosage guidelines—failed to pass in the state legislature. Lane and others advocate for proactive, science-driven regulations to ensure products are safe and accessible for those in need.

Without action, Lane fears many could lose access to a vital tool for managing pain. For more details, read the original opinion piece at STLToday.

A fresh nationwide effort spearheaded by the Kratom Research Institute (KRI) is calling on policymakers to safeguard access to natural kratom while addressing the risks posed by synthetic substitutes like 7-hydroxymitragynine (7OH). The campaign highlights concerns over synthetic 7OH products, which are being marketed as kratom in colorful tablets—often sold without proper regulation or age verification.

KRI’s executive director, Ryan Niddel, emphasized the group’s stance: “We’re not advocating for a kratom ban. Our goal is to ensure synthetic 7OH is regulated through established drug approval channels to protect public health.” Internal research from KRI reveals that the tiny amount of 7OH naturally found in kratom leaves cannot account for the quantities being sold, suggesting most of these products are artificially produced.

The organization is also collecting stories from consumers and healthcare professionals to better understand the impact of both natural and synthetic kratom. For the original article, visit The Herald Journal here.

Rhode Island’s House Bill 5565 seeks to regulate kratom by banning synthetic and semi-synthetic analogs, while allowing the sale of natural kratom products. Lora Romney, president of the International Plant & Herbal Alliance, argues in a recent Providence Journal opinion piece that the real danger lies in adulterated products containing high concentrations of 7-hydroxymitragynine (7-OH), which are engineered to spike psychoactive effects and misrepresent kratom’s safety profile.

Romney emphasizes that natural kratom, supported by extensive research and millions in federal funding, is not dangerously addictive and is well-tolerated at various doses. She points out that the FDA has not declared kratom dangerous, and that many adverse events blamed on kratom are actually linked to synthetic analogs. House Bill 5565 aims to ensure only safe, properly labeled, and age-restricted kratom products remain available to Rhode Islanders.

Colorado has passed the Daniel Bregger Act, a major update to its Kratom Consumer Protection Act, designed to enhance consumer safety and restrict dangerous high-potency kratom products. Signed by Governor Jared Polis, the law mandates clear labeling, bans synthetic and semi-synthetic kratom alkaloids, and limits the presence of 7-hydroxymitragynine to 2% in products. It also prohibits sales to individuals under 21, bans kratom vaporizers, and restricts marketing aimed at children.

Named in memory of Dan Bregger, who died in 2021 after consuming a mislabeled, highly concentrated kratom extract, the act honors his legacy and the advocacy of his father, David Bregger. The Global Kratom Coalition praised the legislation as a model for evidence-based regulation and consumer protection.